Exoskeleton-Assisted Gait Training for Stroke Rehabilitation
This study is looking at how effective using an Indego Exoskeleton (a powered device that helps with walking) is for improving movement and daily activities in people who have had a stroke. Researchers want to see if this special training, when added to standard rehabilitation, helps patients recover better. You could be eligible if you are between 18 and 90 years old, have had a stroke (either hemorrhagic or ischemic), are medically stable, and can stand on your own. The study will measure success by looking at changes in your ability to perform daily tasks (using the Functional Independence Measure, or FIM™) and how far you can walk in two minutes, both at the start and after four weeks of treatment. The current status of this study is unclear.
- Study design
- This interventional study plans to enroll 50 participants who will be randomly assigned to either receive training with the Indego Exoskeleton or standard over-ground gait training, in addition to their usual therapy. This is an open-label trial, meaning both participants and clinicians will know which intervention is being used.
- What's involved
- Participants will receive their daily 3-hours of conventional therapy, plus an hour of either exoskeleton or over-ground gait training 3 times per week for 60 minutes.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your progress will be measured at the start of the study (Day 1) and again after 4 weeks.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Effects of Exoskeleton-Assisted Gait Training on Functional Rehabilitation Outcomes in Patients With Stroke
At a glance
Conditions
NCT03980457
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Oklahoma City VA Health Care System
Oklahoma City, Oklahomastudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Meheroz H Rabadi, MD, MRCPI · PRINCIPAL_INVESTIGATOR · Affiliate; Oklahoma VA Health Care System
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- The Functional Independence Measure (FIM™)Baseline (Day 1) and at 4-weeks to measure change
It measure the degree of disability as well as the progress patients make throughout their medical rehabilitation programs. FIM Scale score varies from minimum of 18 to maximum of 126. Higher score better the outcome.
- The two minute walk test (2-MWT)Baseline (Day 1) and at 4-weeks to measure change
It assess the walking distance over two minutes while moving at a comfortable speed. using any ambulation aids (such as cane, walkers, and rollators) used in everyday life. Normal walking speed is 360 ft.